What is the initial approach to managing extraesophageal contractions?

Management of Extraesophageal Contractions

I need to clarify that the term "extraesophageal contractions" appears to be a misunderstanding or miscommunication. Based on the provided evidence, you likely mean either:

1. Extraesophageal manifestations of GERD (laryngitis, cough, asthma)
2. Hypercontractile esophagus (a primary esophageal motility disorder)

I'll address both interpretations:

---

If You Mean: Extraesophageal Manifestations of GERD

The initial approach should prioritize lifestyle modifications over empiric PPI therapy, as PPIs alone have failed to demonstrate benefit for isolated extraesophageal symptoms in multiple meta-analyses. 1

Initial Diagnostic Approach

• Do NOT start empiric PPI therapy for isolated extraesophageal symptoms (chronic cough, laryngitis, asthma) without documented typical GERD symptoms (heartburn/regurgitation) 1, 2
• Perform esophagogastroduodenoscopy (EGD) after holding PPIs for 2-4 weeks to assess for objective mucosal injury (erosive esophagitis grades B-D, long-segment Barrett's), though most patients will have normal findings 1
• Recognize that laryngoscopy findings (arytenoid erythema, vocal fold edema) are non-specific and can occur in asymptomatic individuals 1
• EGD does not confirm causality between reflux and extraesophageal symptoms, even when GERD is present 1

Treatment Algorithm Based on Symptom Pattern

For patients WITH heartburn/regurgitation plus extraesophageal symptoms:

• Implement lifestyle modifications first: weight loss if BMI >25, head of bed elevation, avoid meals within 2-3 hours of bedtime 3
• Add PPI therapy (esomeprazole 40 mg twice daily, omeprazole 40 mg twice daily, pantoprazole 40 mg twice daily, or rabeprazole 20 mg twice daily) 3
• Expect GI symptoms to respond in 4-8 weeks, but extraesophageal symptoms may take up to 3 months 3

For patients WITHOUT typical GERD symptoms (isolated extraesophageal symptoms):

• Lifestyle modifications ONLY: weight loss, head of bed elevation, avoiding late meals 1, 3
• Do NOT prescribe PPIs empirically - meta-analyses of 8 RCTs found no advantage over placebo for GERD-related chronic laryngitis (RR 1.28; 95% CI 0.94-1.74) 3
• Consider objective reflux testing (ambulatory pH or pH-impedance monitoring) before any PPI trial 2

Management of Treatment Failure

• After one failed 3-month trial, perform esophageal manometry and pH-metry rather than escalating PPI therapy 3
• Do NOT add nocturnal H2-receptor antagonists to twice-daily PPIs - no evidence of improved efficacy 3
• Consider alternative diagnoses including laryngeal hypersensitivity, which may benefit from neuromodulators or behavioral interventions 3

Critical Pitfalls to Avoid

• Current diagnostic tests lack specificity and sensitivity for establishing causality between reflux and extraesophageal symptoms 1
• Laryngoscopy findings alone cannot confirm GERD as the cause of symptoms 1
• Prolonged PPI use carries risks: impaired cognition, bacterial gastroenteritis, pneumonia, hip fractures, vitamin B12 deficiency, hypomagnesemia, chronic kidney disease 3
• Surgery should only be considered in highly selected patients with concomitant heartburn/regurgitation, prior PPI response, and acid exposure time >12% on pH monitoring 1

---

If You Mean: Hypercontractile Esophagus (Primary Motility Disorder)

Start with an empiric trial of a proton pump inhibitor given the significant overlap with GERD, before considering more invasive interventions. 4

Initial Management

• Empiric PPI trial first - significant overlap exists between hypercontractile esophagus and GERD 4
• Consider calcium channel blockers, nitrates, or phosphodiesterase inhibitors to reduce contraction vigor, though symptomatic response is often suboptimal 4

When Medical Therapy Fails

• Endoscopic botulinum toxin injection or pneumatic dilation can be attempted, though response is variable 4
• Per-oral endoscopic myotomy (POEM) may be superior to laparoscopic Heller myotomy for relieving dysphagia, particularly in patients with concurrent EGJ outflow obstruction 4
• Extended esophageal myotomy can relieve symptoms in approximately 75% of patients with clear diagnosis 5

Key Diagnostic Considerations

• Hypercontractile esophagus is diagnosed on high-resolution manometry when ≥20% of swallows show distal contractile integral >8,000 mmHg·s·cm with normal LES relaxation 4
• Provocative testing during HRM can increase detection, reproduce symptoms, and predict delayed esophageal emptying 4
• Presence of EGJ outflow obstruction identifies patients who may benefit from endoscopic treatment targeting the EGJ 4